The HIV-1 Tat protein selectively enhances CXCR4 and inhibits CCR5 expression in megakaryocytic K562 cells

Experimental Biology and Medicine

Volumn 230, Issue 9, 2005, Pages 631-644

  Mondal, Debasis ^a   Williams, Christopher A ^a   Ali, Mussa ^a   Eilers, Mark ^a   Agrawal, Krishna C ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

CCR5; CXCR4; Differentiation; HIV 1; HPCs; K562; Tat

Indexed keywords

BUTYRIC ACID; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; GLYCOPHORIN A; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSACTIVATOR PROTEIN; TRITIUM; VIRUS PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ERYTHROID CELL; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEROTONIN UPTAKE; STATISTICAL SIGNIFICANCE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 27144557035     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020523000905     Document Type: Article

References (73)

1. Norris PJ, Rosenberg ES. CD4(+) T helper cells and the role they play in viral control. J Mol Med 80:397-405, 2002.
2. Boaz MJ, Waters A, Murad S, Easterbrook PJ, D'Sousa E, van Wheeley C, Vyakarnam A. CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects. Clin Exp Immunol 134:454-463, 2003.
3. Philpott SM. HIV-1 coreceptor usage, transmission, and disease progression. Curr HIV Res 1:217-227, 2003.
4. Vicenzi E, Panina-Bodignon P, Vallanti G, Di Lucia P, Poli G. Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1 CD4(+) T cells. J Leukoc Biol 72:913-920, 2002.
5. Ofori H, Jagodzinski PP. Increased in vitro replication of CC chemokine receptor 5-restricted human immunodeficiency virus type 1 primary isolates in Th2 lymphocytes may correlate with AIDS progression. Scand J Infect Dis 36:46-51, 2004.
6. Root MJ, Steger HK. HIV-1 gp41 as a target for viral entry inhibition. Curr Pharm Des B1:805-825, 2004.
7. Wu Y. HIV-1 gene expression: lessons from provirus and nonintegrated DNA. Retrovirology 1:13, 2004.
8. Pumfery A, Deng L, Maddukuri A, de la Fuente C, Li H, Wade JD, Lambert P, Kumar A, Kashanchi F. Chromatin remodeling and modification during HIV-1 Tat-activated transcription. Curr HIV Res 1:343-362, 2003.
9. Liang C, Wainberg MA. The role of Tat in HIV-1 replication: an activator and/or a suppressor? AIDS Rev 4:41-49, 2002.
10. Gendelman HE, Narayan O, Molineaux S, Clements JE, Ghotbi Z. Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci U S A 82:7086-7090, 1985.
11. Staskus KA, Couch L, Bitterman P, Retzel EF, Zupancic M, List J, Haase AT. In situ amplification of visna virus DNA in tissue sections reveals a reservoir of latently infected cells. Microb Pathog 11:67-76, 1991.
12. Rodes B, Toro C, Paxinos E, Poveda E, Martinez-Padial M, Benito JM, Jimenez V, Wrin T, Bassani S, Soriano V. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection. AIDS 18:1109-1116, 2004.
13. Bukrinsky MI, Stanwick TL, Dempsey MP, Stevenson M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254:423-427, 1991.
14. Perelson AS, Essunger P, Ho DD. Dynamics of HIV-1 and CD4+ lymphocytes in vivo. AIDS 11 Suppl A:S17-24, 1997.
15. Ogg GS, Jin X, Bonhoeffer S, Moss P, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Hurley A, Markowitz M, Ho DD, McMichael AJ, Nixon DF. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol 73:797-800, 1999.
16. Chun TW, Davey RT Jr, Ostrowski M, Shawn Justement J, Engel D, Mullins JI, Fauci AS. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat Med 6:757-761, 2000.
17. Dybul M, Daucher M, Jensen MA, Hallahan CW, Chun TW, Belson M, Hidalgo B, Nickle DC, Yoder C, Metcalf JA, Davey RT, Ehler L, Kress-Rock D, Nies-Kraske E, Liu S, Mullins JI, Fauci AS. Genetic characterization of rebounding human immunodeficiency virus type-1 in plasma during multiple interruptions of highly active antiretroviral therapy. J Virol 77:3229-3237, 2003.
18. Bagnara GP, Zauli G, Giovannini M, Re MC, Furlini G, La Placa M. Early loss of circulating hemopoietic progenitors in HIV-1 infected subjects. Exp Hematol 18:426-430, 1990.
19. Chen JJ, Huang JC, Shirtliff M, Briscoe E, Ali S, Cesani F, Paar D, Cloyd MW. CD4 lymphocytes in the blood of HIV(+) individuals migrate rapidly to lymph nodes and bone marrow: support for homing theory of CD4 cell depletion. J Leukoc Biol 72:271-278, 2002.
20. Comar M, Simonelli C, Zanussi S, Paoli P, Vaccher E, Tirelli U, Giacca M. Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection. J Clin Invest 100:893-903, 1997.
21. Wu Y. HIV-1 gene expression: lessons from provirus and nonintegrated DNA. Retrovirology 1:13, 2004.
22. Shen H, Cheng T, Preffer FI, Dombkowski D, Tomasson MH, Golan DE, Yang O, Hofmann W, Sodroski JG, Luster AD, Scadden DT. Intrinsic human immuno-deficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J Virol 73:728-737, 1999.
23. Canque B, Marandin A, Rosenzwajg M, Louache F, Vainchenker W, Gluckman JC. Susceptibility of human bone marrow stromal cells to human immunodeficiency virus (HIV). Virology 208:779-783, 1995.
24. Granelli-Piperno A, Finkel V, Delgado E, Steinman RM. Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells. Curr Biol 9:21-29, 1999.
25. Chelucci C, Federico M, Guerriero R, Mattia G, Casella I, Pelosi E, Testa U, Mariani G, Hassan HJ, Peschle C. Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes. Blood 91:1225-34, 1998.
26. David SA, Smith MS, Lopez GJ, Adany I, Mukherjee S, Buch S, Goodenow MM, Narayan O. Selective transmission of R5-tropic HIV type 1 from dendritic cells to resting CD4+ T cells. AIDS Res Hum Retroviruses 17:59-68, 2001.
27. Wang H, English NJ, Reid CD, Merson JE, Knight SC. Role of betachemokines in HIV-1 infection of dendritic cells maturing from CD34+ stem cells. J Acquir Immune Defic Syndr 21:179-188, 1999.
28. Voulgaropoulou F, Pontow SE, Ratner L. Productive infection of CD34+-cell-derived megakaryocytes by X4 and R5 HIV-1 isolates. Virology 269:78-85, 2000.
29. Majka M, Rozmyslowicz T, Lee B, Murphy SL, Pietrzkowski Z, Gaulton GN, Silberstein L, Ratajczak MZ. Bone marrow CD34(+) cells and megakaryoblasts secrete beta-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV. J Clin Invest 104:1739-1749, 1999.
30. de Roda Husman AM, Schuitemaker H. Chemokine receptors and the clinical course of HIV-1 infection. Trends Microbiol 6:244-249, 1998.
31. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, Lange JM, Schattenkerk JK, Miedema F, Tersmette M. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 66:1354-1360, 1992.
32. Gupta SK, Pillarisetti K, Lysko PG. Modulation of CXCR4 expression and SDF-1alpha functional activity during differentiation of human monocytes and macrophages. J Leukoc Biol 66:135-143, 1999.
33. Song W, Yahara S, Maeda Y, Yusa K, Tanaka Y, Harada S. Enhanced infection of an X4 strain of HIV-1 due to capping and colocalization of CD4 and CXCR4 induced by capsianoside G, a diterpene glycoside. Biochem Biophys Res Commun 283:423-429, 2001.
34. Jeang KT, Xiao H, Rich EA. Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem 274:28837-28840, 1999.
35. Huigen MC, Kamp W, Nottet HS. Multiple effects of HIV-1 transactivator protein on the pathogenesis of HIV-1 infection. Eur J Clin Invest 34:57-66, 2004.
36. Hottiger MO, Nabel GJ. Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivator p300 and CREB binding protein. J Virol 72:8252-8256, 1998.
37. Zauli G, Davis BR, Re MC, Visani G, Furlini G, La Placa M. Tat protein stimulates production of TGF-b1 by marrow macrophages: a potential mechanism for HIV-1 induced hematopoietic suppression. Blood. 80:3036-3043, 1992.
38. Sastry KJ, Marin MC, Nehete PN, McConnell K, el-Naggar AK, McDonnell TJ. Expression of human immunodeficiency virus type I tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene 13:487-493, 1996.
39. Mondal D, Agrawal KC. Effect of HIV-1 Tat protein on butyric acid induced differentiation in a hematopoietic progenitor cell line. AIDS Res Hum Retro 12:1529-1535, 1998.
40. Wang L, Mondal D, La Russa VF, Agrawal KC. Suppression of clonogenic potential of human bone marrow mesenchymal stem cells by HIV type 1: putative role of HIV type 1 tat protein and inflammatory cytokines. AIDS Res Hum Retroviruse. 18:917-931, 2002.
41. Huang L, Bosch I, Hofmann W, Sodroski J, Pardee AB. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J Virol 72:8952-8960, 1998.
42. Xiao H, Neuveut C, Tiffany HL, Benkirane M, Rich EA, Murphy PM, Jeang KT. Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A 97:11466-11471, 2000.
43. Ghezzi S, Noonan DM, Aluigi MG, Vallanti G, Cota M, Benelli R, Morini M, Reeves JD, Vicenzi E, Poli G, Albini A. Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat. Biochem Biophys Res Commun 270:992-996, 2000.
44. Secchiero P, Zella D, Capitani S, Gallo RC, Zauli G. Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells. J Immunol 162:2427-2431, 1999.
45. Gibellini D, Re MC, Vitone F, Rizzo N, Maldini C, La Placa M, Zauli G. Selective up-regulation of functional CXCR4 expression in erythroid cells by HIV-1 Tat protein. Clin Exp Immunol 131:428-435, 2003.
46. Chelucci C, Casella I, Federico M, Testa U, Macioce G, Pelosi E, Guerriero R, Mariani G, Giampaolo A, Hassan HJ, Peschle C. Lineagespecific expression of human immunodeficiency virus (HIV) receptor/ coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance. Blood 94:1590-1600, 1999.
47. Tytgat GA, van den Brug MD, Voute PA, Smets LA, Rutgers M. Human megakaryocytes cultured in vitro accumulate serotonin but not meta-iodobenzylguanidine whereas platelets concentrate both. Exp Hematol 30:555-563, 2002.
48. DuPont BR, Grant SG, Oto SH, Bigbee WL, Jensen RH, Langlois RG. Molecular characterization of glycophorin A transcripts in human erythroid cells using RT-PCR, allele-specific restriction, and sequencing. Vox Sang 68:121-129, 1995.
49. Rutka JT, Muller M, Hubbard SL, Forsdike J, Dirks PB, Jung S, Tsugu A, Ivanchuk S, Costello P, Mondal S, Ackerley C, Becker LE. Astrocytoma adhesion to extracellular matrix: functional significance of integrin and focal adhesion kinase expression. J Neuropathol Exp Neurol 58:198-209, 1999.
50. Matsunaga T, Warltier DC, Tessmer J, Weihrauch D, Simons M, Chilian WM. Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis. Am J Physiol Heart Circ Physiol 285:H352-H358, 2003.
51. Chun TW, Engel D, Berrey MM, Shea T, Corey L, Fauci AS. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A 95:8869-8873, 1998.
52. Calenda V, Chermann JC. HIV Tat protein potentiates in vitro granulomonocytic progenitor cell growth. Eur J Haematol 54:180-185, 1995.
53. Calenda V, Sebahoun G, Chermann JC. Modulation of normal human erythropoietic progenitor cells in long-term liquid cultures after HIV-1 infection. AIDS Res Hum Retroviruses 8:61-67, 1992.
54. Calenda V, Chermann JC. Severe in vitro inhibition of erythropoiesis and transient stimulation of granulopoiesis after bone-marrow infection with eight different HIV-2 isolates. AIDS 6:943-948, 1992.
55. Cole JL, Marzec UM, Gunthel CJ, Karpatkin S, Worford L, Sundell IB, Lennox JL, Nichol JL, Harker LA. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood 91:3239-3246, 1998.
56. Majka M, Ratajczak J, Baj-Krzyworzek M, Kijowski J, Reca R, Machalinski B, Kubicze K, Ratajczak MZ. Biological significance of chemokine receptor expression by normal human megakaryoblasts. Folia Histochem Cytobiol 39:235-244, 2001.
57. Riviere C, Subra F, Cohen-Solal K, Cordette-Lagarde V, Letestu R, Auclair C, Vainchenker W, Louache F. Phenotypic and functional evidence for the expression of CXCR4 receptor during megakaryocytopoiesis. Blood 93:1511-1523, 1999.
58. Franchin G, Zybarth G, Dai WW, Dubrovsky L, Reiling N, Schmidtmayerova H, Bukrinsky M, Sherry B. Lipopolysaccharide inhibits HIV-1 infection of monocyte-derived macrophages through direct and sustained down-regulation of CCR5. J Immunol 164:2592-2601, 2000.
59. Bosco MC, Reffo G, Puppo M, Varesio L. Hypoxia inhibits the expression of the CCR5 chemokine receptor in macrophages. Cell Immunol 228:1-7, 2004.
60. Kang CD, Do IR, Kim KW, Ahn BK, Kim SH, Chung BS, Jhun BH, Yoo MA. Role of Ras/ERK-dependent pathway in the erythroid differentiation of K562 cells. Exp Mol Med 31:76-82, 1999.
61. Lee CH, Yun HJ, Kang HS, Kim HD. ERK/MAPK pathway is required for changes of cyclin D1 and B1 during phorbol 12-myristate 13-acetate-induced differentiation of K562 cells. IUBMB Life 48:585-591, 1999.
62. Miyazaki R, Ogata H, Kobayashi Y. Requirement of thrombopoietininduced activation of ERK for megakaryocyte differentiation and of p38 for erythroid differentiation. Ann Hematol 80:284-291, 2001.
63. Debili N, Coulombel L, Croisille L, Katz A, Guichard J, Breton-Gorius J, Vainchenker W. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood 88:1284-1296, 2001.
64. Hong Y, Martin JF, Vainchenker W, Erusalimsky JD. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells. Blood 87:123-131, 1996.
65. Herrera R, Hubbell S, Decker S, Petruzzelli L. A role for the MEK/ MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells. Exp Cell Res 238:407-414, 1998.
66. Zauli G, Gibellini D, Vitale M, Secchiero P, Celeghini C, Bassini A, Pierpaoli S, Marchisio M, Guidotti L, Capitani S. The induction of megakaryocyte differentiation is accompanied by selective Ser133 phosphorylation of the transcription factor CREB in both HEL cell line and primary CD34+ cells. Blood 92:472-480, 1998.
67. Gibellini D, Bassini A, Pierpaoli S, Bertolaso L, Milani D, Capitani S, La Placa M, Zauli G. Extracellular HIV-1 Tat protein induces the rapid Ser133 phosphorylation and activation of CREB transcription factor in both Jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells. J Immunol 160:3891-3898, 1998.
68. Blobel GA, Nakajima T, Eckner R, Montminy M, Orkin SH. CREBbinding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc Natl Acad Sci U S A 95:2061-2066, 1998.
69. Cristillo AD, Highbarger HC, Dewar RL, Dimitrov DS, Golding H, Bierer BE. Up-regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP responsive element. FASEB J 16:354-364, 2002.
70. Moriuchi M, Moriuchi H, Fauci AS. GATA-1 transcription factor transactivates the promoter for CCR5, a coreceptor for human immunodeficiency virus type 1 entry. Blood 93:1433-1435, 1999.
71. Hodohara K, Fujii N, Yamamoto N, Kaushansky K. SDF-1α acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Blood 95:769-775, 2000.
72. Gibellini D, Bassini A, Re MC, Ponti C, Miscia S, Gonelli A, La Placa M, Zauli G. SDF-1α induces a selective inhibition of human erythroid development via the functional upregulation of Fas/CD95 ligand. Br J Haematol 111:432-440, 2000.
73. Gibellini D, Re MC, Miscia S, La Placa M, Zauli G. Extracellular HIV-1 Tat protein activates the transcriptional repressor ICER in both Jurkat cell line and peripheral blood mononuclear cells. AIDS 14:1059-1061, 2000.